Unknown

Dataset Information

0

Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells.


ABSTRACT: Autophagy is a critical mechanism in both cancer therapy resistance and tumor suppression. Monoclonal antibodies have been documented to kill tumor cells via apoptosis, antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). In this study, we report for the first time that chLym-1, a chimeric anti-human HLA-DR monoclonal antibody, induces autophagy in Raji Non-Hodgkin's Lymphoma (NHL) cells. Interestingly, inhibition of autophagy by pharmacological inhibitors (3-methyladenine and NH4Cl) or genetic approaches (siRNA targeting Atg5) suppresses chLym-1-induced growth inhibition, apoptosis, ADCC and CDC in Raji cells, while induction of autophagy could accelerate cytotoxic effects of chLym-1 on Raji cells. Furthermore, chLym-1-induced autophagy can mediate apoptosis through Caspase 9 activation, demonstrating the tumor-suppressing role of autophagy in antilymphoma effects of chLym-1. Moreover, chLym-1 can activate several upstream signaling pathways of autophagy including Akt/mTOR and extracellular signal-regulated kinase 1/2 (Erk1/2). These results elucidate the critical role of autophagy in cytotoxicity of chLym-1 antibody and suggest a potential therapeutic strategy of NHL therapy by monoclonal antibody chLym-1 in combination with autophagy inducer.

SUBMITTER: Fan J 

PROVIDER: S-EPMC3756084 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Autophagy plays a critical role in ChLym-1-induced cytotoxicity of non-hodgkin's lymphoma cells.

Fan Jiajun J   Zeng Xian X   Li Yubin Y   Wang Shaofei S   Wang Ziyu Z   Sun Yun Y   Gao Hongjian H   Zhang Guoping G   Feng Meiqing M   Ju Dianwen D  

PloS one 20130828 8


Autophagy is a critical mechanism in both cancer therapy resistance and tumor suppression. Monoclonal antibodies have been documented to kill tumor cells via apoptosis, antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). In this study, we report for the first time that chLym-1, a chimeric anti-human HLA-DR monoclonal antibody, induces autophagy in Raji Non-Hodgkin's Lymphoma (NHL) cells. Interestingly, inhibition of autophagy by pharmacological inhibitors  ...[more]

Similar Datasets

| S-EPMC3824669 | biostudies-literature
2014-09-24 | GSE51813 | GEO
| S-EPMC8569585 | biostudies-literature
| S-EPMC7055468 | biostudies-literature
2014-09-24 | E-GEOD-51813 | biostudies-arrayexpress
| S-EPMC8305599 | biostudies-literature
| S-EPMC4614396 | biostudies-literature
2014-09-24 | GSE51726 | GEO
| S-EPMC6649101 | biostudies-literature
| S-EPMC3138544 | biostudies-other